Peritoneal Dialysis (PD) is a Renal Replacement Therapy for patients with renal insufficiency that has been used more frequently in recent years. In PD treatment, catheter are used to provide access to the peritoneal cavity, allowing the dialysate to be introduced and removed from the abdomen. The aim of this study is to evaluate the safety and efficacy of long-term treatment with PD catheters (developed by Fresenius Medical Care (FME)) in adult and paediatric patients treated with CAPD or APD. Safety and performance parameters of the catheters will be analyzed, as well as data on PD treatment outcome, such as Peritoneal Clearance and Peritoneal Ultrafiltration.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Safety variables
Timeframe: Every 6 months (± 2 months, as per centre practice)
Safety variables
Timeframe: Every 6 months (± 2 months, as per centre practice)
Safety variables
Timeframe: Every 6 months (± 2 months, as per centre practice)
Safety variables
Timeframe: Every 6 months (± 2 months, as per centre practice)
Safety variables
Timeframe: Every 6 months (± 2 months, as per centre practice)
Safety variables
Timeframe: Every 6 months (± 2 months, as per centre practice)